After a breast cancer diagnosis, the focus is — understandably — on treating the cancer. Bone health is rarely part of the initial conversation. But for women on aromatase inhibitors, those who experienced chemotherapy-induced menopause, or those who underwent surgical removal of the ovaries, bone density loss is not a distant long-term concern. It begins during treatment, progresses silently, and significantly elevates fracture risk unless it is actively addressed.
The good news is that physical therapy — specifically structured, progressive weight-bearing and resistance exercise — is one of the most powerful non-pharmacological tools available for preserving bone density during and after breast cancer treatment. At Thera Physical and Occupational Therapy in Midtown Manhattan, we work with breast cancer patients to protect bone health through evidence-based exercise programming, fall prevention, and rehabilitation that considers the specific mechanisms driving bone loss in this population.
Why breast cancer treatment accelerates bone loss
Estrogen plays a fundamental role in maintaining bone density. It suppresses the activity of osteoclasts — the cells responsible for breaking down bone — while supporting the bone-building activity of osteoblasts. When estrogen levels fall rapidly, as they do with aromatase inhibitors, chemotherapy-induced ovarian failure, or surgical menopause, osteoclast activity increases and bone mineral density (BMD) declines significantly faster than in natural menopause.
The clinical data on this is sobering. Premenopausal women who experience ovarian failure from chemotherapy can lose up to 7.6% of bone mineral density annually — compared with less than 1% for a healthy premenopausal woman. Aromatase inhibitors produce accelerated bone loss in all women who take them; the greatest losses are seen in younger women treated with GnRH agonist plus aromatase inhibitor combinations. Over a five-to-ten year course of hormonal therapy, cumulative bone loss can reach clinically significant levels — particularly at the lumbar spine and hip, the sites most relevant to fracture risk.
Several additional factors compound this risk in breast cancer patients specifically:
- Vitamin D deficiency — common in breast cancer patients and a co-contributor to bone loss
- Reduced physical activity — during chemotherapy and surgical recovery, when fatigue and pain limit movement, bone is not receiving the mechanical loading that stimulates bone formation
- Chemotherapy-induced peripheral neuropathy — can increase falls risk, amplifying the consequences of reduced BMD
- Corticosteroid use — often used as part of chemotherapy protocols, with known bone density effects
How exercise protects bone density: the mechanism
Bone is not static tissue. It responds dynamically to mechanical loading — the physical forces placed on it during movement. When weight-bearing and resistance exercise create mechanical stress on bones, this stimulus activates osteoblasts (bone-building cells) and suppresses osteoclast activity, producing a net bone-forming response. This principle is the foundation of all exercise-based bone health interventions: bone that is regularly loaded mechanically maintains or increases its density; bone that is unloaded loses it.
For breast cancer patients experiencing treatment-induced bone loss, this means that the right exercise program does not simply slow the rate of loss — it can actively counteract the osteoclast-stimulating effect of estrogen depletion. The exercise stimulus and the hormonal bone-resorption signal are acting in opposite directions, and a sufficiently structured exercise program can tip the balance toward preservation.
What the clinical evidence shows
The evidence for exercise-based bone protection in breast cancer survivors is substantial and growing. Several landmark studies are worth understanding:
Resistance plus impact training (PMID 21424279)
A randomized controlled trial assigned postmenopausal breast cancer survivors — including women on aromatase inhibitors — to one year of three-times-weekly progressive resistance training plus impact exercise (jumping), or a control program of low-intensity stretching. The results were striking: women in the resistance plus impact group preserved BMD at the lumbar spine (+0.47%) compared to significant loss in controls (-2.13%), a statistically significant difference (P=0.001). Notably, lean mass gains from resistance training were greatest among women currently taking aromatase inhibitors — suggesting the exercise benefit is particularly pronounced in exactly the group at highest bone loss risk.
Long-term aerobic and impact training — the BREX study (PMC7929955)
The five-year follow-up of the Finnish BREX randomized trial found that weight-bearing impact aerobic exercise and circuit training during breast cancer treatment produced lasting benefits compared to controls — with better bone density outcomes in the exercise group at the femoral neck sustained five years after the intervention began.
Practical conclusion
The evidence consistently supports progressive resistance training combined with weight-bearing impact exercise as the most effective exercise approach for bone density preservation in breast cancer survivors on hormonal therapy. Low-impact aerobic exercise (walking, cycling, swimming) provides important cardiovascular and fatigue benefits but is less effective for bone than resistance and impact components.
What physical therapy provides for bone health after breast cancer
A structured, progressive, supervised exercise program
The evidence-based exercise components for bone protection in breast cancer survivors are specific: progressive resistance training targeting major muscle groups (with particular attention to the muscles around the spine and hip, which are the most clinically important fracture sites), combined with weight-bearing impact activities appropriate to the patient's current fitness and joint status. This is not a generic gym program. It is a clinically designed protocol that starts from your individual baseline — accounting for your current bone density, joint health, lymphedema status, any peripheral neuropathy, and treatment phase — and progresses systematically.
Your physical therapist at Thera will assess your current strength, balance, and functional capacity, design a program appropriate for your specific risk profile, and supervise your progression to ensure both efficacy and safety. For patients with significant joint pain from aromatase inhibitors, the program must also address those symptoms — which is one reason a supervised clinical program is more appropriate than unsupervised gym attendance.
Balance training and fall prevention
Bone density loss only translates to fracture if a fall occurs. Chemotherapy-induced peripheral neuropathy, fatigue, and the deconditioning that accompanies cancer treatment all increase fall risk independently of bone density. A physical therapy program that addresses balance, proprioception, lower extremity strength, and gait stability reduces the risk that reduced BMD will result in a fracture.
Balance training is integrated into every exercise program at Thera for breast cancer patients at bone density risk — it is not an add-on. Your therapist will assess your specific balance deficits and include appropriate progressions from supported to unsupported balance challenge throughout your program.
Posture and spinal mobility
Vertebral compression fractures — small fractures in the bodies of the spinal vertebrae — are a common consequence of spinal osteoporosis and can produce significant pain, height loss, and postural change (kyphosis). Physical therapy addresses spinal mobility, thoracic extension strength, and the postural adaptations that reduce compressive load on the vertebral bodies. This is particularly relevant for patients who have also received radiation to the chest wall, where soft tissue restriction may already be affecting thoracic mobility. Learn more about our approach to scar and soft tissue management at Thera.
Education on bone-protective behaviors and risk reduction
Your therapist will provide guidance on the practical daily habits that support bone health alongside formal exercise: appropriate calcium and vitamin D intake (for discussion with your oncologist or physician), bone-smart movement patterns for daily activities, and precautions that reduce fracture risk during the period of maximum bone vulnerability. This education component is part of every Thera patient's care program.
When to start and what to expect
The optimal time to begin a bone-protective exercise program is before significant bone loss has occurred — ideally at the start of hormonal therapy, or immediately after chemotherapy-induced menopause. Bone that has been preserved is easier to maintain than bone that has been lost and must be rebuilt.
If you are already months or years into aromatase inhibitor therapy and have not had a bone-focused exercise program, it is not too late. Bone responds to mechanical loading at any stage of loss. A dual-energy X-ray absorptiometry (DEXA) scan, ordered by your oncologist or physician, provides an objective baseline of your current bone density and identifies which sites require the most attention in your exercise program.
Results from a structured program are not immediate — meaningful BMD changes take months to accumulate. What improves more quickly is strength, balance, functional fitness, and joint pain — outcomes that are clinically meaningful in their own right while the bone-protective effects develop over time.
Bone health and breast cancer rehabilitation at Thera in NYC
At Thera Physical and Occupational Therapy, bone health is integrated into our breast cancer rehabilitation program for patients on aromatase inhibitors or those who have experienced treatment-induced menopause. We provide individualized exercise programming, fall prevention assessment, lymphedema-safe exercise design, and the ongoing clinical monitoring that ensures your program advances safely and effectively.
Our clinic is at 115 West 30th Street in Midtown Manhattan, steps from Penn Station. Sessions are always one-on-one. No referral is needed. If you are concerned about bone density loss during or after breast cancer treatment, contact our team today to schedule an evaluation.
Bone density loss during breast cancer treatment is real, significant, and begins early — particularly for women on aromatase inhibitors or those who experienced chemotherapy-induced or surgical menopause. Progressive resistance training combined with weight-bearing impact exercise is the most evidence-supported non-pharmacological intervention for bone protection in this population. A randomized controlled trial demonstrated lumbar spine BMD preservation (+0.47%) in the exercise group versus significant loss (-2.13%) in controls — a clinically meaningful difference that was most pronounced in women currently taking aromatase inhibitors. Physical therapy provides the clinical structure, supervision, and individualization that translates this evidence into a safe, effective program for each patient.
If you are on aromatase inhibitors, have experienced treatment-induced menopause, or want to protect your bone health during breast cancer treatment, contact our team today to schedule an evaluation at our Midtown Manhattan clinic.
No referral needed · New York State allows direct access to physical and occupational therapy for up to 10 visits or one month without a physician's script.